Double-blind randomized controlled trial investigating the neurocognitive effects of pig liver-derived phosphatidylcholine in healthy adult volunteer.

Double-blind randomized controlled trial investigating the neurocognitive effects of pig liver-derived phosphatidylcholine in healthy adult volunteer. - The neurocognitive effects of pig liver-derived phosphatidylcholine

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000036364

Enrollment

Registered

2019-04-01

Start date

2019-02-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteer

Interventions

active (phosphatidylcholine) placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: healthy adult volunteer.

Exclusion criteria

Exclusion criteria: 1. pregnancy 2. do not undergo neurophysiological test 3. dietary of having memory effect

Design outcomes

Primary

Measure	Time frame
Cognitive function was evaluated at the pre-dose point and after 4 weeks of active treatment by means of WMS-R	—

Countries

Japan,Asia(except Japan)

Contacts

Public ContactTatsuro Mori

Mori neurosurgical clinic clinic

research@mhrri.com03-3788-1777

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026